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A B S T R A C T
Background: Epidemiological evidence on the influence of long-term exposure to traffic-related particulate
matter (TPM10) on heart rate variability (HRV) is weak.
Objective: To evaluate the association of long-term exposure (10 years) with TPM10 on the regulation of the
autonomic cardiovascular system and heart rate dynamics (HRD) in an aging general population, as well as
potential modifying effects by the a priori selected factors sex, smoking status, obesity, and gene variation in
selected glutathione S-transferases (GSTs).
Methods: We analyzed data from 1593 SAPALDIA cohort participants aged≥50 years. For each participant,
various HRV and HRD parameters were derived from 24-hour electrocardiogram recordings. Each parameter
obtained was then used as the outcome variable in multivariable mixed linear regression models in order to
evaluate the association with TPM10. Potential modifying effects were assessed using interaction terms.
Results: No association between long-term exposure to TPM10 and HRV/HRD was observed in the entire study
population. However, HRD changes were found in subjects without cardiovascular morbidity and both HRD and
HRV changes in non-obese subjects without cardiovascular morbidity. Subjects without cardiovascular mor-
bidity with homozygous GSTM1 gene deletion appeared to be more susceptible to the effects of TPM10.
Conclusion: This study suggests that long-term exposure to TPM10 triggers adverse changes in the regulation of
the cardiovascular system. These adverse effects were more visible in the subjects without cardiovascular dis-
ease, in whom the overall relationship between TPM10 and HRV/HRD could not be masked by underlying
morbidities and the potential counteracting effects of related drug treatments.
1. Introduction
Short- and long-term exposure to particulate matter (PM) air pol-
lution has been associated with increased cardiovascular morbidity and
mortality. Investigations of short-term effects have shown greater risks
in susceptible populations, such as the elderly, individuals with dia-
betes, patients with preexisting coronary heart disease, chronic lung
disease, or heart failure, and individuals with low education or socio-
economic status (Brook et al., 2010; Pieters et al., 2012; Pope III et al.,
2004). Current or former smokers, obese subjects, and women could
also be susceptible populations (Brook et al., 2010).
Possible mechanisms underlying these associations include effects
on the autonomic nervous system. Heart rate variability (HRV) is a
useful non-invasive measure to assess the autonomic regulation of
cardiac rhythm (Task Force, 1996). Lower HRV is associated with
higher cardiovascular morbidity and mortality, and has proved itself as
an important prognostic tool for several cardiovascular conditions
(Bigger Jr. et al., 1992; Kleiger et al., 1987; Task Force, 1996; Tsuji
et al., 1996). There is strong epidemiological evidence that short-term
PM exposure (in days) is associated with reductions in most indices of
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HRV, and the association might be more pronounced among the el-
derly, patients with preexisting cardiovascular disease or diabetes, or
people with reduced antioxidative defenses (Brook et al., 2010;
Mordukhovich et al., 2015; Park et al., 2005; Pieters et al., 2012). In-
deed, response to air pollutants has been shown to be modified by genes
that modulate endogenous oxidative stress (Bergamaschi et al., 2001;
Schwartz et al., 2005b). In particular, recent observations have shown
strong modifications of the relationships of HRV with PM, second-hand
smoke, and BMI, by glutathione S-transferase (GST) (Adam et al., 2017;
Baccarelli et al., 2008; Park et al., 2006; Probst-Hensch et al., 2008;
Schwartz et al., 2005b), a family of enzymes involved in the metabolism
of reactive oxygen species and xenobiotic compounds, and showing
common genetic variations (Schwartz et al., 2005b).
Although long-term PM exposure is known to have a stronger effect
on cardiovascular morbidity and mortality than acute exposure, there is
limited or weak epidemiological evidence that HRV is altered by low-
level, but long-term exposure (in years) to PM (Brook et al., 2010), and
whether there is a greater risk in susceptible populations. Indeed, stu-
dies on the chronic impact of PM air pollution on HRV are scarce (Adam
et al., 2012; Adam et al., 2014; Mordukhovich et al., 2015) and the
American Heart Association has stated that there is a lack of evidence
regarding long-term effects of air pollution on HRV (Brook et al., 2010).
It is conceivable that the stronger effect of long-term air pollution ex-
posure, compared to short-term exposure, reflects the accumulation of
molecular damage in the cardiovascular system in response to long-
term air pollution exposure. This molecular damage may be visible in
lowered HRV in part. Accumulated molecular damage may also pre-
dispose the heart to acute effects of air pollution at a later stage.
Finally, there is increasing evidence that the regulation of the car-
diovascular system involves nonlinear control mechanisms (Rajendra
Acharya et al., 2006; Task Force, 1996) which can be best characterized
using nonlinear time series analysis techniques (Goldberger and West,
1987; Meyer and Stiedl, 2003; Pikkujamsa et al., 2001; Pincus, 1991;
Rajendra Acharya et al., 2006; Vandeput et al., 2012). The recent im-
plementation of such methods to evaluate the influence of current
smoking and smoking cessation on heart rate dynamics in the large
epidemiological dataset of SAPALDIA (Swiss Cohort Study on Air Pol-
lution and Lung and Heart Disease in Adults), which allowed for the
control of most known potential confounders, enabled us to unveil long-
term alterations in former heavy smokers who might need up to
15–25 years to fully recover (Girard et al., 2015).
By applying the same kind of approach, the present study aimed
first at evaluating the influence of low-level, but long-term exposure
(i.e. over a 10-year period) to traffic-related particulate matter (TPM10)
on the regulation of the autonomic cardiovascular system and heart rate
dynamics in an aging general population. In a further analysis, we used
ambient NO2 concentrations, as well as ambient PM10 concentrations,
as an alternative proxy for exposure to traffic-related pollutants.
Second, we focused our investigation on the subgroups with or without
cardiovascular morbidity (i.e., cardiovascular disease and/or hy-
pertension). Finally, we investigated potential modifications of these
effects by the a priori selected factors sex, smoking status, obesity, and
gene variation in selected glutathione S-transferases (GSTs) in the entire
study population and in the subgroups with or without cardiovascular
morbidity.
2. Methods
2.1. Ethics statement
The study was approved by the Central Ethics Committee of the
Swiss Academy of Medical Sciences and the Cantonal Ethics
Committees for each of the study areas. Each subject was informed in
detail about the health examinations and signed a written informed
consent form before any of the health examinations were conducted.
2.2. Study population
This study is part of the SAPALDIA study which was designed to
assess the health effects of long-term exposure to air pollutants in the
Swiss adult population. The study design has been described in detail
elsewhere (Ackermann-Liebrich et al., 2005; Martin et al., 1997). In
brief, the SAPALDIA cohort (n=9651) was enrolled in 1991, and
consisted of a random sample of the Swiss population aged 18 to
60 years, recruited from the local registries of inhabitants in eight areas
featuring distinct geographical and environmental conditions.
In 2002, the follow-up study included 8047 (83.4%) participants. A
random sample of 1846 out of 4417 participants, aged≥50 years un-
derwent a 24-hour electrocardiogram (ECG) Holter recording to assess
HRV, as previously described in detail (Felber Dietrich et al., 2006).
Exclusion criteria were general or spinal anaesthesia within 8 days
before the ECG recording (n= 5), a myocardial infarction within
3months prior to the examination (n= 2), taking digitalis (n= 6), and
an artificial internal pacemaker (n= 0). Participants with recordings
showing atrial fibrillation (n=12), ECG duration lower than 18 h
(n= 73), ECG of insufficient quality (n=6), or non-valid data on HRV
(n= 96) were also excluded (Felber Dietrich et al., 2006). By com-
paring the 1607 remaining participants with SAPALDIA follow-up
participants above age 50, but without HRV measurements (N= 2810),
it was noted the study participants to be less likely ever smokers (56.8%
vs. 59.8%), physically active (41.3% vs. 47.9%), or diagnosed with
diabetes (3.8% vs. 6.9%), but more likely to be hypertensive (47.5% vs.
44.1%), or take heart medication (24.5% vs. 21.5%) (Adam et al.,
2012). This current analysis is restricted to 1593 participants with valid
data on HRV, cardiovascular risk factors, and TPM10 exposure.
2.3. Questionnaires and measurements
Extensive health examinations and a detailed assessment of personal
risk factors were conducted in 1991 and repeated in 2002 in the 8047
(83.4%) participants of the follow-up study (Ackermann-Liebrich et al.,
2005). Information about questionnaires and biological measurements
performed at these two time points has been reported elsewhere
(Ackermann-Liebrich et al., 2005; Felber Dietrich et al., 2006; Martin
et al., 1997). The 24-hour ECG and measurements such as blood pres-
sure, heart rate, uric acid, and high-sensitivity C-reactive protein were
performed only in 2002.
2.3.1. Measures of heart rate variability and heart rate dynamics
Time series analysis parameters of heart rate variability were cal-
culated for each individual time series of inter-beat intervals (RR series)
generated from the 24-hour ECG recordings performed in 2002.
The traditional time domain measure used was the standard de-
viation of normal interbeat intervals (SDNN) (Task Force, 1996). Ad-
ditionally, a power-law relationship between the power spectral density
(PSD) of the interbeat interval time series and frequency was de-
termined by estimating the slope β of the linear best-fit of the PSD as a
function of the frequency on a double logarithmic scale. In our previous
study, related to heart rate dynamics and smoking exposure, we found a
positive association between this slope β and smoking exposure (Girard
et al., 2015).
We used nonlinear time series analysis methods to quantify and
characterize the heart rate dynamics. Several nonlinear analysis
methods of heart rate behaviour have been developed to obtain a more
comprehensive quantification of the heart rate dynamic fluctuations
(Anonymous, 1996; Goldberger, 1996). Characterization of the com-
plexity in the fluctuation behaviour of system signals holds enormous
promise for providing new understandings of the regulatory mechan-
isms of physiological systems and how they change with diseases.
However, the translation of such involved mathematical concepts into
the clinical and epidemiological fields is challenging and is still ex-
ploratory. Furthermore, to the best of authors5 knowledge, associations
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between air pollutants exposure and heart rate dynamic fluctuations
have not been investigated yet. Consequently, we calculated several
heart rate dynamics (HRD) parameters (Goldberger and West, 1987;
Meyer and Stiedl, 2003; Pikkujamsa et al., 2001; Pincus, 1991;
Rajendra Acharya et al., 2006; Vandeput et al., 2012), and report on the
results for those parameters which appeared to best capture the asso-
ciation of long-term exposure to TPM10 with heart rate dynamic fluc-
tuations. Description of the other parameters is provided in the Sup-
plemental Material.
• Exponent α: we used detrended fluctuation analysis (DFA) to mea-
sure the presence or absence of fractal correlation properties in
signals. This method has been validated for interbeat intervals time
series (Peng et al., 1995). The fractal long-range correlations are
characterized by a scaling exponent α. A fractal-like signal results in
α= 1. White Gaussian noise (totally random signal) results in a
value of 0.5. In healthy young subjects, it is closer to 1, and this
value falls within different ranges for various types of cardiac ab-
normalities (Pikkujamsa et al., 2001; Rajendra Acharya et al., 2006).
In our previous study, related to heart rate dynamics and smoking
exposure, we found an inverse association between α and smoking
exposure (Girard et al., 2015).• Largest Lyapunov exponent: detection of chaos in a time series can
be done by measuring the largest Lyapunov exponent in the ap-
propriate phase space embedding (Rosenstein et al., 1993). It
quantifies the exponential divergence of initially close state-space
trajectories and estimates the amount of chaos in a system. The
extent to which chaos relates to physiological or pathological dy-
namics is a subject of active investigation and some controversy
(Goldberger et al., 2000). In our previous study, related to heart rate
dynamics and smoking exposure, we found an inverse association
between the largest Lyapunov exponent and smoking exposure
(Girard et al., 2015).
More details about the choice, implementation, and properties of
the aforementioned time series analysis methods are described in the
Supplemental Material.
2.3.2. Air pollutant exposure estimation
Monitoring of air pollutants was conducted between 1991 and
2002. Consequently, individual estimates of home outdoor exposure to
TPM10 could be obtained for each of the 10 years preceding the re-
spective subject's ECG recording (i.e., for the period 1991–2002) using
a dispersion modeling and temporal interpolation approach (Liu et al.,
2007) and taking into account residential moves. The dispersion model
made use of different source-specific emissions, thus, it was possible to
derive spatial distributions of source-specific PM10 such as TPM10
(Adam et al., 2012; Kunzli et al., 2009). The 10 annual means were then
averaged to obtain estimates of mean residential home-outdoor ex-
posure to TPM10 over the 10 years preceding the ECG recording.
The description of the modeling of residential exposure has been
described in detail elsewhere (Liu et al., 2007). Briefly, estimates of
residential PM10 exposure were obtained for each of the years 1991 to
2002 using a dispersion modeling and temporal interpolation approach
(Liu et al., 2007). As for traffic-related PM10, these annual values were
used to obtain estimates of average residential exposure to PM10 over
10 years. Estimates of residential NO2 exposure were derived from land-
use regression models of NO2-passive sampler measurements conducted
in 1993 and 2003 across the eight study areas. These models involved
dispersion model predictions, land-use and meteorological variables.
Annual estimates for the years 1991 to 2002 were obtained by temporal
inter- and extrapolation based on fixed-site monitor measurements. As
for PM10, these annual values were used to obtain estimates of average
residential home-outdoor exposure to NO2 over 10 years.
2.3.3. Definition of cardiovascular morbidity
There was no cardiovascular morbidity if there was no evidence for
cardiovascular disease or hypertension (i.e., the subject had no physi-
cian diagnosed heart disease, no major cardiovascular medication in-
take, and no hypertension). Major cardiovascular medication included
beta-blockers, angiotensin-converting-enzyme (ACE) inhibitors, angio-
tensin II receptor antagonists, calcium channel blockers, diuretic med-
ications, antiarrhythmic drugs class I+ III, sympathomimetic medica-
tions. Absence of hypertension was defined as absence of a physician
diagnosis of hypertension, blood pressure in the hypertensive range,
and antihypertensive medication.
2.3.4. Genotyping
GSTM1 and GSTT1 genotypes are commonly investigated in studies
assessing the interactions between gene variation in GST and air pol-
lution because these genes are expressed in the respiratory tract, are
involved in detoxification of chemicals present in diesel exhaust parti-
cles or environmental carcinogens, and have common functional var-
iant alleles (Gilliland et al., 2004). GSTM1 and GSTT1 genes have both
a common allele that results in a lack of the respective protein. The
GSTM1 gene is deleted in approximately half of the white population,
and lack to the GSTM1 protein has been associated with an enhanced
nasal allergic response to PM air pollution (Schwartz et al., 2005b).
The genotyping has been described in detail elsewhere (Probst-
Hensch et al., 2008). In brief, all subjects were genotyped for GSTM1
(UniGene ID Hs.301961; UniGene 2008a) and GSTT1 (UniGene
Hs.268573; UniGene 2008b) gene deletions.
2.4. Statistical analysis
2.4.1. Descriptive analysis
Results are expressed as numbers and percentages for categorical
variables and as a mean ± standard deviation or median [25th per-
centile; 75th percentile] for continuous variables, according to their
distribution.
2.4.2. Multivariable analysis
Each parameter describing the HRV, or heart rate dynamics, was
used as the outcome variable in multivariable linear mixed effects re-
gression models in order to evaluate the association with long-term
exposure to TPM10. Estimates were expressed (1) for a one interquartile
range-increment in TPM10, in order to enable comparison of effect size
with other air pollutants; (2) for an increase of 1 μg/m3 in TPM10, in
order to facilitate comparisons with other studies. Initial inspection of
the outcome variables showed a skewed distribution of the residuals for
some of them, which were therefore log-transformed. Estimated effects
on these variables are presented as percentage changes in geometric
means. All the models included random intercepts for the study areas
and were adjusted for established and potential confounding factors
(Adam et al., 2012; Adam et al., 2014; Felber Dietrich et al., 2006), i.e.,
sex (male as reference), age (for an increase of 1 year), age2, body mass
index (BMI, for an increase of 1 kg/m2), BMI2, alcohol consumption
(< 1 glass/day as reference, ≥1 glass/day), duration of weekly phy-
sical activity to the point of getting out of breath or sweating (never as
reference, between 0.5 h and 2 h, ≥2 h/week), daily exposure to en-
vironmental tobacco smoke (none as reference, between 0 h and 3 h,
≥3 h/day), diabetes (no as reference, yes), smoking group (lifelong
non-smoker as reference, former light smoker (< 20 pack-years),
former heavy smoker (≥ 20 pack-years), current light smoker, current
heavy smoker), uric acid concentration (μmol/L), high-sensitivity C-
reactive protein (hsCRP) (mg/L), street and railway noise exposure
(mean dB(A) per night), sine and cosine functions of the day of ex-
amination with a period of 1 year (to model potential seasonal pat-
terns), education level (high as reference, middle, low), employment
category (employed as reference, unemployed, homemaker, pensioner),
occupational exposure (no as reference, yes if currently exposed to
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dust/gas/smoke/aerosols/fumes/vapors at the working place), cardio-
vascular morbidity (no as reference, yes).
2.4.3. Investigation of susceptible groups
Potential modifying effects of cardiovascular morbidity, sex, as well
as of inflammation and oxidative stress related parameters such as
smoking status (defined as ever smoker or lifelong non-smoker), obesity
(defined as BMI≥ 30 kg/m2), and known whole gene deletion poly-
morphisms of GSTM1 and GSTT1 previously found to modify the
smoking-HRV association in the SAPALDIA cohort study (Probst-
Hensch et al., 2008) were assessed for each outcome using interaction
terms.
2.4.4. Sensitivity analyses
Given the small number of participants with diabetes in the sub-
population without cardiovascular morbidity, the potential modifying
effect of diabetes could not be assessed using an interaction term.
Instead, participants with a physician diagnosis of diabetes were ex-
cluded in a sensitivity analysis.
As previous work on the SAPALDIA cohort had found stronger ad-
verse effects of TPM10 on the traditional parameters of HRV among
participants under angiotensin-converting-enzyme (ACE) inhibitor
therapy (Adam et al., 2012), the potential modifying effect of ACE in-
hibitor therapy was also assessed for each of the present outcomes using
a respective interaction term.
As the effects observed may have consisted of longer term and acute
components, multivariable models were adjusted for short-term ex-
posure to PM10 (i.e., level of PM10 on the day preceding the HRV-
measurement) in another sensitivity analysis (short-term exposure to
TPM10 was not available). Data related to short-term PM10 exposure
were available at ambient air pollution monitoring stations (NABEL,
Cantons).
Finally, it might be hypothesized that hsCRP is on the causal
pathway and/or an effect of air pollution as well. In this case, adjusting
for hsCRP might results in “over-adjustments”. Consequently, effects of
TPM10 were assessed without adjusting for hsCRP and estimated effect
sizes were compared with those observed when adjusting for hsCRP.
2.4.5. Associations with other air pollutants
In addition, we investigated the relationship of HRV/HRD-variables
with the 10-year means of PM10 and NO2. Methods are provided in the
Supplemental Material. Correlation between TPM10 and PM10, as well
as between TPM10 and NO2, were assessed using Spearman correlation
coefficient (ρ).
All tests were two-sided with a significance level of 0.05. Statistical
analysis was performed using R, Version 3.3.1 (Computing R
Foundation for Statistical Computing, 2008.
3. Results
3.1. Study population
The study population consisted of 1593 subjects. The mean age of
the subjects was 60.5 ± 6.2 years. Demographic characteristics, life-
style factors, cardiovascular health and diabetes, long-term exposure to
air pollution, and GST genotypes are summarized in Table 1. A more
detailed description has been reported elsewhere (Adam et al., 2012;
Girard et al., 2015).
3.2. Relationship between long-term exposure to TPM10 and HRV/HRD
Neither in the entire study population nor in any of the subgroups
defined according to sex, smoking status, obesity and GST genotypes,
did we observe any significant association between long-term exposure
to TPM10 and HRV/HRD parameters (Tables 2, 4, 5 and Tables S1–S3).
However, stratification by cardiovascular morbidity revealed
significant associations between TPM10 and the HRD parameters slope
β (0.2 [0.03, 0.3], p= 0.01) and largest Lyapunov exponent (−0.01
[−0.02, −0.001], p= 0.03) in subjects without cardiovascular mor-
bidity, while the corresponding associations in subjects with
Table 1
Characteristics of the study population and subpopulations investigated.
Characteristic Entire study
population
(n=1593)
MD Subpopulation
without
cardiovascular
morbidity (n= 510)
MD
Demographic characteristics
Age, years 60.5 ± 6.2 – 59.6 ± 6.01 –
Sex, men 773 (48.5%) – 200 (39.2%) –
BMI, kg/m2 26.7 ± 4.34 3 25.1 ± 3.78 –
Education – –
Low 144 (9.0%) 48 (9.4%)
Middle 1048 (65.8%) 325 (63.7%)
High 401 (25.2%) 137 (26.9%)
Employment 10 6
Employed 862 (54.5%) 291 (57.7%)
Homemaker 352 (22.2%) 121 (24%)
Unemployed 81 (5.1%) 21 (4.2%)
Pensioner 288 (18.2%) 71 (14.1%)
Lifestyle factors
Smoking status 60 12
Lifelong non-smoker 692 (45.1%) 230 (46.2%)
Current light smoker 65 (4.2%) 28 (5.6%)
Current heavy smoker 222 (14.5%) 71 (14.3%)
Former light smoker 314 (20.5%) 112 (22.5%)
Former heavy smoker 240 (15.7%) 57 (11.4%)
Time elapsed since
cessation, years
7 3
< 15 154/547 (28.2%) 46/166 (27.7%)
15–25 150/547 (27.4%) 44/166 (26.5%)
≥25 243/547 (44.4%) 76/166 (45.8%)
Daily ETS exposure,
hours
2 2
None 1253 (78.8%) 407 (80.1%)
< 3 216 (13.6%) 63 (12.4%)
≥3 122 (7.7%) 38 (7.5%)
Alcohol, ≥1 glass/day 731 (45.9%) 2 211 (41.5%) 2
Weekly physical activity 14 5
None 666 (42.2%) 203 (40.2%)
30min–1 h 516 (32.7%) 183 (36.2%)
2 h or more 397 (25.1%) 119 (23.6%)
Noise exposure, dB(A) 56.6 ± 7.31 7 57 ± 7.11 3
Cardiovascular health and diabetes
Diabetes 80 (5.0%) – 9 (1.8%) –
Heart disease diagnosed
by a doctor
126 (7.9%) – 0 (0%) –
Hypertension 861 (54.0%) – 0 (0%) –
Major cardiovascular
medication (≥1)
403 (31.7%) 321 0 (0%) –
ACE inhibitor therapy 102 (8.0%) 321 0 (0%) –
Uric acid, μmol/L 326 ± 85.93 56 300 ± 77.01 15
hs-CRP, mg/L 1.2 [0.6;2.6] 56 1 [0.5;2] 15
Heart rate (bpm) 74.2 ± 9.1 1 74.6 ± 7.85 1
SDNN (ms) 136.5 ± 35.22 – 140.5 ± 34.49 –
α 2.5 ± 0.4 – 2.5 ± 0.3 –
Slope β −2.6 ± 1.0 – −2.7 ± 0.9 –
Largest Lyapunov
exponent
0.2 ± 0.09 – 0.2 ± 0.08 –
Air pollutants exposure
Occupational exposure 400 (25.2%) 3 131 (25.8%) 2
Long-term PM10
exposure, μg/m3
20.9 [17.8;25.1] 9 20.2 [17.1;24.7] 5
Long-term traffic-
related PM10
exposure, μg/m3
1.9 [1.2;3.1] 9 1.5 [1.1;2.9] 5
Long-term NO2
exposure, μg/m3
24.0 [17.4;34.6] 7 21.6 [16.2;35.3] 4
GST genotypes
GSTM1 deletion 781 (52.3%) 100 240 (50.3%) 33
(continued on next page)
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cardiovascular morbidity were not statistically significant (Table 3,
Fig. 1). Effect modification was statistically significant in the case of β
(p= 0.04) and marginally significant in the case of largest Lyapunov
exponent (p=0.08).
Estimates for an increase in TPM10 of 1 μg/m3, instead of an inter-
quartile range, are provided in the Tables S4–S10.
3.3. Investigation of the subgroup without cardiovascular morbidity
In the subgroup of subjects without cardiovascular morbidity,
TPM10 effects became particularly visible in non-obese subjects both in
the HRV parameter (SDNN: −4.4% [−7.9%, 0.04%], p=0.05) and in
the HRD parameters (α: −2.3% [−4.8%, 0.01%], p=0.05; slope β:
0.2 [0.02, 0.3], p= 0.02; largest Lyapunov exponent: −0.02 [−0.03,
−0.004], p= 0.01), while the corresponding associations in obese
subjects were not statistically significant. For SDNN, the respective
difference was statistically significant (p= 0.01) (Table 4, Fig. 1).
There was no evidence of effect modification by sex (Table S1) and
by smoking status (Table S2).
We found strongly significant associations between TPM10 and
HRV/HRD parameters (SDNN: −5.7% [−10.6%, −0.6%], p=0.03;
slope β: 0.2 [0.08, 0.4], p < 0.001) in subjects with homozygous
GSTM1 gene deletion, i.e., in subjects with a weakened oxidative stress
defense (Table 5, Fig. 1). Note that slope β is indeed expected to be
increased in case of deleterious effects on heart rate dynamics. Con-
versely, the HRD parameter α was significantly decreased (−3.4%
[−6.1%, −0.8%], p=0.01) in subjects without GSTM1 deficiency.
When stratifying by GSTT1 genotype, we observed significant as-
sociations in subjects without GSTT1 deficiency (Table S3). However,
coefficients in subjects with homozygous GSTT1 gene deletion were
similar to those in subjects without GSTT1 deficiency, and confidence
intervals were very broad. The small sample size of the subgroup of
subjects with homozygous GSTT1 gene deletion (n=69) might have
limited the statistical power of these analyses. Consequently, there is no
evidence of effect modification by GSTT1 genotype.
Estimates, provided above for an interquartile range, are ad-
ditionally provided for an increase of 1 μg/m3 in TPM10 in the
Supplemental Material (Tables S5–S10).
3.4. Sensitivity analyses
As previously shown in the SAPALDIA cohort study, there was a
strong decrease in SDNN (−12.9% [−23.9%, −1.4%], p=0.03) in
subjects under ACE inhibitor therapy (Table S11). In contrast, we found
no evidence that the effects of TPM10 on the HRD parameters were
modified by ACE inhibitor intake.
Exclusion of subjects with diabetes made associations even stronger
Table 1 (continued)
Characteristic Entire study
population
(n= 1593)
MD Subpopulation
without
cardiovascular
morbidity (n= 510)
MD
GSTT1 deletion 261 (17.5%) 100 79 (16.6%) 33
GSTM1 and GSTT1
deletions
145 (9.7%) 100 41 (8.6%) 33
ACE inhibitor, angiotensin-converting-enzyme inhibitor; BMI, body mass index;
ETS, Environmental Tobacco Smoke; hs-CRP, high-sensitivity C-reactive pro-
tein; GST, glutathione S-transferase; MD, missing data; PM, particulate matter;
SDNN, standard deviation of all NN intervals.
Long-term traffic-related PM10, PM10, and NO2 exposure correspond to the
average of the 10 estimates of annual mean residential exposure to traffic-re-
lated PM10, PM10, and NO2, respectively, over the 10 years preceding the ECG
recording (i.e., for the period 1992–2002).
Values shown are mean ± standard deviation, median [25th percentile; 75th
percentile] and numbers (percentages).
GST genotypes correspond to homozygous gene deletions of GSTM1 or GSTT1.
Smokers were defined as heavy smokers if they had smoked≥20 pack-years.
Table 2
Association between HRV and heart rate dynamics parameters (outcome vari-
able) and traffic-related PM10 in linear mixed effects regression models.
Entire study population (n=1237a)
% ΔGM, 95%CI or ΔAM, 95%CI p-Value
SDNN −1.3% [−3.7%, 1.1%] 0.27
α −0.7% [−2.5%, 1.0%] 0.42
Slope β −0.005 [−0.08, 0.07] 0.89
Largest Lyapunov exponent −0.002 [−0.01, 0.006] 0.63
All the models include random intercepts for the study areas and are adjusted
for gender, age, BMI, smoking status, environmental tobacco smoke exposure,
alcohol consumption, physical activity, uric acid, high-sensitivity C-reactive
protein, noise exposure, seasonal effect, education level, employment category,
occupational exposure, diabetes, and cardiovascular morbidity. Estimates are
expressed for a one interquartile range-increment in traffic-related PM10 (i.e.,
2 μg/m3). Values shown are percentage change in the geometric mean (% ΔGM)
and 95% confidence interval (95%CI), or change in arithmetic mean (ΔAM)
(i.e., regression coefficient) and 95%CI.
SDNN, standard deviation of all NN intervals.
a Number of subjects included in the regression models (i.e., with no missing
values on variables included in the regression models).
Table 3
Association between HRV and heart rate dynamics parameters (outcome variable) and traffic-related PM10 in linear mixed effects regression models stratified by
cardiovascular morbidity.
Cardiovascular morbidity (n= 775a) No cardiovascular morbidity (n=462a) Interactionb
% ΔGM, 95%CI
or ΔAM, 95%CI
p-Value % ΔGM, 95%CI
or ΔAM, 95%CI
p-Value p-Value
SDNN −0.5% [−3.5%, 2.4%] 0.76 −3.0% [−6.6%, 1.2%] 0.15 0.36
α −0.06% [−2.5%, 2.4%] 0.96 −1.8% [−4.4%, 0.4%] 0.11 0.24
Slope β −0.06 [−0.2, 0.06] 0.36 0.2 [0.03, 0.3] 0.01 0.04
Largest Lyapunov exponent 0.003 [−0.005, 0.01] 0.47 −0.01 [−0.02, −0.001] 0.03 0.08
All the models include random intercepts for the study areas and are adjusted for gender, age, BMI, smoking status, environmental tobacco smoke exposure, alcohol
consumption, physical activity, uric acid, high-sensitivity C-reactive protein, noise exposure, seasonal effect, education level, employment category, occupational
exposure, and diabetes. Estimates are expressed for a one interquartile range-increment in traffic-related PM10 (i.e., 2 μg/m3). Values shown are percentage change in
the geometric mean (% ΔGM) and 95% confidence interval (95%CI), or change in arithmetic mean (ΔAM) (i.e., regression coefficient) and 95%CI.
SDNN, standard deviation of all NN intervals.
a Number of subjects included in the regression models (i.e., with no missing values on variables included in the regression models).
b Interaction between TPM10 and cardiovascular morbidity.
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in non-obese subjects for SDNN (−4.6% [−8.1%, −0.9%], p=0.04)
and α (−2.4% [−4.9%, −0.1%], p=0.04) (Table S12), as well as in
subjects without GSTT1 deletion for α (−2.4% [−4.9%, −0.02%],
p=0.05) and slope β (0.2 [0.0007, 0.3], p= 0.05) (Table S13).
Adjustment for short-term exposure to PM10 led only to minor
changes in the results (data not shown) and did not alter conclusions.
Estimated effect sizes observed from models with or without ad-
justment for hsCRP were very similar (data not shown), excluding po-
tential issues related to eventual over-adjustments.
3.5. Relationship between other air pollutants and HRV/HRD
Results for long-term exposure to PM10 and NO2 were very similar
to those found for TPM10 (Figs. S1–S2, Tables S14–S41), which is
consistent with medium to high correlations between these pollutants
(ρTPM10/PM10= 0.86, p < 0.001; ρTPM10/NO2= 0.76, p < 0.001). The
effects sizes of long-term exposure to PM10 and NO2 were smaller
though. More detailed comparisons of NO2 and PM10 findings with
TPM10 findings are provided in the Supplemental Material.
4. Discussion
4.1. Main findings
This study evaluated the influence of long-term exposure to TPM10
on HRV and heart rate dynamics. While we did not find any significant
associations in the entire study population, we observed significant
associations of long-term exposure to TPM10 with the HRD parameters
slope β and largest Lyapunov exponent in subjects without cardiovas-
cular morbidity. Findings for PM10 and NO2 were similar, though the
effect sizes were smaller.
The null findings in the subgroup with diseases is no proof of no
effect in this population. Not only is statistical power reduced but the
pathophysiologic heterogeneity of this sub-population is certainly
larger, with a range of other factors (including in particular various
drugs) possibly intervening with the relevant pathways related to air
pollution. If this is the case, statistical signals in this subgroup are ex-
pected to be much “noisier” than in the more homogeneous group of
health people. In particular, effects of TPM10 may have been counter-
acted by drug treatments in subjects with cardiovascular disease, which
would explain why the TPM10–HRV/HRD relationship became more
visible in subjects without cardiovascular disease and related drug
treatments. Moreover, a damaged heart may no longer react well to
both positive and negative influences, in which case HRV/HRD might
thus be decoupled from external influences. Finally, the TPM10 effects
became even more visible in the subgroup of non-obese subjects
without cardiovascular morbidity, as shown by both HRV and HRD
parameters, while the underlying health conditions and the counter-
acting effects of drug treatments (e.g., statins) might have weakened the
TPM10–HRV/HRD relationship in obese subjects.
Fig. 1. Percentage change in geometric mean (% ΔGM) and 95% confidence interval (95%CI) of SDNN and alpha, or change in arithmetic mean (ΔAM) (i.e.,
regression coefficient) and 95%CI of slope beta and largest Lyapunov exponent, for a one interquartile range-increment in traffic-related PM10 (i.e., 2 μg/m3), in
models stratified by cardiovascular morbidity in the entire study population (A), and by obesity (B) and GSTM1 (C) in the subpopulation without cardiovascular
morbidity.
GST, glutathione S-transferase; SDNN, standard deviation of all NN intervals.
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Additionally, our findings support the hypothesis that TPM10 might
impact in part through oxidative stress pathways. We found significant
associations between TPM10 and HRV/HRD parameters in subjects with
homozygous GSTM1 gene deletion (as shown by SDNN and slope β), in
accordance with a previous oxidative stress gene pathway analysis
conducted in SAPALDIA on smoking, air pollution and lung function
(Curjuric et al., 2012).
Finally, the fact that significant adverse effects of TPM10 were
revealed in subjects without cardiovascular morbidity only for HRD
parameters suggests that measuring changes in the complexity of heart
rate dynamics in response to environmental exposures, might unveil
subtle but important changes in the regulatory mechanisms of the
cardiovascular system not detectable by traditional parameters of heart
rate variability.
Table 4
Association between HRV and heart rate dynamics parameters (outcome variable) and traffic-related PM10 in linear mixed effects regression models stratified by
obesity.
Entire study population Non-obese (n=974a) Obese (n= 263a) Interactionb
% ΔGM, 95%CI
or ΔAM, 95%CI
p-Value % ΔGM, 95%CI
or ΔAM, 95%CI
p-Value p-Value
SDNN −1.4% [−4.0%, 1.7%] 0.33 −1.3% [−6.2%, 3.8%] 0.61 0.72
α −0.6% [−2.3%, 1.2%] 0.53 −0.6% [−4.5%, 3.2%] 0.76 0.88
Slope β −0.01 [−0.1, 0.08] 0.82 0.05 [−0.1, 0.2] 0.54 0.34
Largest Lyapunov exponent 0.0001 [−0.008, 0.008] 0.98 −0.006 [−0.02, 0.009] 0.41 0.21
Subpopulation without
cardiovascular morbidity
Non-obese (n=415a) Obese (n= 47a) Interactionb
% ΔGM, 95%CI
or ΔAM, 95%CI
p-Value % ΔGM, 95%CI
or ΔAM, 95%CI
p-Value p-Value
SDNN −4.4% [−7.9%, 0.04%] 0.05 5.0% [−6.0%, 17.2%] 0.38 0.01
α −2.3% [−4.8%, 0.01%] 0.05 6.0% [−0.8%, 13.2%] 0.08 0.13
Slope β 0.2 [0.02, 0.3] 0.02 0.4 [−0.1, 0.8] 0.14 0.56
Largest Lyapunov exponent −0.02 [−0.03, −0.004] 0.01 0.01 [−0.03, 0.05] 0.60 0.11
All the models include random intercepts for the study areas and are adjusted for gender, age, BMI, smoking status, environmental tobacco smoke exposure, alcohol
consumption, physical activity, uric acid, high-sensitivity C-reactive protein, noise exposure, seasonal effect, education level, employment category, occupational
exposure, diabetes, and cardiovascular morbidity (except for the subpopulation without cardiovascular morbidity). Estimates are expressed for a one interquartile
range-increment in traffic-related PM10 (i.e., 2 μg/m3). Values shown are percentage change in the geometric mean (% ΔGM) and 95% confidence interval (95%CI),
or change in arithmetic mean (ΔAM) (i.e., regression coefficient) and 95%CI.
SDNN, standard deviation of all NN intervals.
a Number of subjects included in the regression models (i.e., with no missing values on variables included in the regression models).
b Interaction between TPM10 and obesity.
Table 5
Association between HRV and heart rate dynamics parameters (outcome variable) and traffic-related PM10 in linear mixed effects regression models stratified by
GSTM1 genotype.
Entire study population Deletion in GSTM1 (n= 620a) No deletion in GSTM1 (n=572a) Interactionb
% ΔGM, 95%CI
or ΔAM, 95%CI
p-Value % ΔGM, 95%CI
or ΔAM, 95%CI
p-Value p-Value
SDNN −2.2% [−5.3, 1.1] 0.19 −0.6% [−3.5%, 2.4%] 0.69 0.38
α 0.5% [−1.9, 3.1] 0.68 −1.7% [−4.0%, 0.4%] 0.12 0.23
Slope β 0.04 [−0.08, 0.2] 0.48 −0.01 [−0.1, 0.1] 0.82 0.65
Largest Lyapunov exponent −0.002 [−0.01, 0.01] 0.76 −0.002 [−0.01, 0.007] 0.66 0.79
Subpopulation without
cardiovascular morbidity
Deletion in GSTM1 (n= 227a) No deletion in GSTM1 (n= 217a) Interactionb
% ΔGM, 95%CI
or ΔAM, 95%CI
p-Value % ΔGM, 95%CI
or ΔAM, 95%CI
p-Value p-Value
SDNN −5.7% [−10.6%, −0.6%] 0.03 −0.6% [−5.5%, 4.6%] 0.82 0.11
α 0.5% [−2.1%, 3.2%] 0.72 −3.4% [−6.1%, −0.8%] 0.01 0.21
Slope β 0.2 [0.08, 0.4] <0.001 0.05 [−0.1, 0.2] 0.59 0.29
Largest Lyapunov exponent −0.01 [−0.03, 0.005] 0.16 −0.02 [−0.03, 0.001] 0.08 0.57
All the models include random intercepts for the study areas and are adjusted for gender, age, BMI, smoking status, environmental tobacco smoke exposure, alcohol
consumption, physical activity, uric acid, high-sensitivity C-reactive protein, noise exposure, seasonal effect, education level, employment category, occupational
exposure, diabetes, and cardiovascular morbidity (except for the subpopulation without cardiovascular morbidity). Estimates are expressed for a one interquartile
range-increment in traffic-related PM10 (i.e., 2 μg/m3). Values shown are percentage change in the geometric mean (% ΔGM) and 95% confidence interval (95%CI),
or change in arithmetic mean (ΔAM) (i.e., regression coefficient) and 95%CI.
GST, glutathione S-transferase; SDNN, standard deviation of all NN intervals.
a Number of subjects included in the regression models (i.e., with no missing values on variables included in the regression models).
b Interaction between TPM10 and GSTM1 genotype.
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4.2. Strengths and weaknesses of the study
To the best of our knowledge, this is the first study examining the
influence of low-level, but long-term, particulate matter air pollution
exposure on parameters describing the HRV and heart rate dynamics
(using nonlinear time series analysis methods). Additional strengths of
the present study include the population-based design, involving a
random sample of the Swiss population; the large number of partici-
pants; and the detailed information available on participants, allowing
for the control of most potential confounders.
A limitation of this study is the absence of a physiological inter-
pretation of the parameters calculated with methods from nonlinear
dynamics. The lack of physiological interpretation of such metrics
constitutes a major limitation for their use (Francesco et al., 2012;
Goldberger et al., 2000; Manor and Lipsitz, 2013). Though it is rea-
sonable to assume that these mathematical concepts could help gain
insight into mechanisms underlying systems fluctuation behaviour
(e.g., modulations of heart period), efforts are needed to improve our
understanding of their physiological correlates. In the present study,
this uncertainty, as well as the absence of reference values, limited the
interpretation of observed associations. Another limitation is that
multiple testing could have led to spurious association with novel HRV
parameters. However, the objective of the study was to estimate asso-
ciations, not to test formal hypotheses. The statistical uncertainty of the
estimates is described by their 95% confidence intervals. Finally, the
small sample size of some subgroups, as well as the low prevalence of
some genotypes, which limited statistical power of the explanatory
analyses. The relevance of oxidative stress as a mediating mechanism
and susceptibility determinant needs broader exposome approaches in
the future (Fiorito et al., 2018).
4.3. Comparison of the study results to other studies
To the best of our knowledge, the association between long-term
traffic-related particulate matter exposure and HRV has only been ex-
amined in the SAPALDIA cohort study (TPM10 levels averaged over a
10 year period) (Adam et al., 2012; Adam et al., 2014), and by Mor-
dukhovich et al., who evaluated sub-chronic (3–84 days) and longer-
term (1 year) PM2.5 or black carbon (a marker of traffic pollution) ex-
posure in relation to HRV (Mordukhovich et al., 2015). These studies
did not observe any consistent overall associations.
Interestingly, in the present study, we observed significant asso-
ciations between heart rate dynamics and TPM10 only in the subgroup
of subjects without cardiovascular morbidity (i.e., no hypertension or
heart disease). These findings are in line with those from Barclay et al.
who did not observe any hematological or electrocardiogram response
to ambient air pollution in patients with cardiac failure, thought to be a
susceptible group (Barclay et al., 2009), while, in contrast to their
earlier findings, they observed such associations in healthy elderly
people (Seaton et al., 1999). They concluded that modern cardiac
therapy was likely to give a measure of protection against the adverse
cardiac effects of air pollution.
Several studies have provided evidence that the relation between
HRV and cardiovascular drug therapies varies and depends on the type
of therapy. Adam et al. observed that the adjusted HRV of subjects
treated with ACE inhibitors or beta blockers was generally increased,
while the HRV of subjects treated with angiotensin receptor blockers,
calcium channel blockers, or diuretics, was decreased when compared
with the average HRV levels of participants without any heart medi-
cation intake (Adam et al., 2012). Furthermore, they provided sug-
gestive evidence that participants under ACE inhibitor treatment may
represent a specific subgroup susceptible to the adverse effects of
TPM10 on HRV. In some other studies, beta blockers (Gold et al., 2000;
Park et al., 2005), calcium channel blockers (Park et al., 2005) and
statins (Schwartz et al., 2005b) were shown to attenuate the effects of
air pollutants; while another study found no evidence of effect
modification by beta blockers (Schwartz et al., 2005a). These findings
suggest that response to long-term TPM10 exposure might result from
the relative contribution of both the underlying cardiovascular condi-
tion and the counteracting effects of drug treatments, which might in
turn explain the heterogeneous effects of short- and long-term exposure
to PM air pollution found in subjects with a cardiovascular morbidity
(Buteau and Goldberg, 2016; Chuang et al., 2005; Holguin et al., 2003;
Park et al., 2005; Pieters et al., 2012; Schwartz et al., 2005a).
The TPM10-HRV/HRD relationship became even more visible when
we focused on healthier subjects in the subgroup of subjects without
cardiovascular morbidity (i.e., non-obese subjects, and subjects without
diabetes). These findings are consistent with those from Yingying et al.,
who found greater reductions in HRV in relation to PM10 exposure in
subjects with low Framingham risk score (i.e., low global cardiac risks)
(Feng et al., 2015).
We found significant associations in subjects with homozygous
GSTM1 gene deletion, which is in line with previous studies having
indicated that air pollutants might impact in part through oxidative
stress pathways (Pieters et al., 2012; Probst-Hensch et al., 2008;
Schwartz et al., 2005b). Conversely, the HRD parameter α was sig-
nificantly decreased in subjects without GSTM1 deficiency. This ob-
servation might be explained by the fact that those subjects are likely to
be healthier than the subjects with homozygous GSTM1 gene deletion
(i.e., not likely to have systemic inflammation and oxidative stress) and
thus, similarly to our findings in non-obese subjects, TPM10 effects
might be visible in such subjects while being masked in the others.
Our findings support the hypothesis that long-term air pollution
effects may lead the accumulation of molecular damage in the cardio-
vascular system, while short-term air pollution exposure might lead to
increased risk of acute cardiovascular disease events in persons with a
cardiovascular diagnosis. This hypothesis is supported by a) sensitivity
analyses that showed that short-term exposure effects do not confound
long-term exposure effects, b) stronger long-term than short-term ef-
fects on cardiovascular disease mortality (Brook et al., 2010), and c) our
observation that long-term effects were more pronounced in healthier
persons, while short-term effects are generally seen to be stronger in
persons with a cardiovascular diagnosis (Brook et al., 2010; Pieters
et al., 2012; Pope III et al., 2004). The joint influence of short- and long-
term influence in persons with and without existing disease should be
further evaluated in future studies.
Finally, we found very similar results for long-term exposure to
PM10 and NO2 to those found for TPM10, though the effects sizes of
long-term exposure to PM10 and NO2 were smaller. These findings are
in line with those from Sanyal et al., who confirmed that PM has a long-
term impact on mortality and morbidity and who observed that ex-
posure to NO₂ could also lead to increased health risks (Sanyal et al.,
2018).
4.4. Relevance of the study and implications for policymakers
First, this study provides evidence of the adverse effects of long-
term exposure to TPM10 on HRV and heart rate dynamics in subjects
without cardiovascular disease, which are believed to be less suscep-
tible than specific subpopulations with morbidities (e.g., the elderly,
patients with preexisting cardiovascular disease or diabetes, obese
subjects) though. However, further studies are needed to see whether
these alterations in HRV/HRD in healthy people are in part on the
pathologic pathway of the many studies confirming a causal role of air
pollution in shortening life expectancy.
Second, this study provides evidence that the TPM10-HRV/HRD
relationship in subjects with cardiovascular morbidity might be mod-
ified by both the underlying cardiovascular condition and the related
treatments. Thus, some cardiac therapies, for a given underlying car-
diovascular condition, might be protective against the adverse cardiac
effects of air pollution, whereas some other cardiac therapies/condi-
tions might render subjects particularly susceptible to those effects.
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Alternatively, effects of treatments not controlled in our analyses could
result in stronger and possibly heterogeneous effects on the same out-
comes, thus, the detection of subtle effects of air pollution may be
possible only in much larger populations of patients. Further studies
investigating the TPM10-HRV/HRD relationship in subjects with cardi-
ovascular morbidity are therefore necessary.
5. Conclusions
In conclusion, findings from the present study indicate that long-
term exposure to TPM10, even at low levels, may trigger adverse
changes in the regulation of the cardiovascular system and in the heart
rate dynamics. These adverse effects were more visible in healthier
subjects, in whom the overall TPM10-HRV/HRD relationship could not
be not modified by an underlying cardiovascular condition, obesity, or
weakened oxidative stress defense, and the potential counteracting ef-
fects of related drug treatments. Future studies need to evaluate the
predictive value of the observed heart rate dynamics differences for all
cause and cardiovascular morbidity and mortality.
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